fda compounding semaglutide news october 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Diabetes advocacy group discourages use

Formulated with well-loved hydrator Squalane, our balm leverages its emollience to provide immediate, long-lasting hydration and skin barrier suppor t

Ask a member of your care team for a referral or call the number above to make an appointment

Our providers are available between appointments for questions and concerns

Weight loss plateaus are a common and often frustrating experience for patients using Zepbound (tirzepatide), a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist approved by the FDA for chronic weight management

Dulaglutide, liraglutide, and exenatide caused less diarrhea than tirzepatide and semaglutide